AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted, focusing on 2006 through October 2012 and …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted, focusing on 2006 through October 2012 and …

1.1. Methodology and Evidence Review Late-breaking clinical trials presented at the 2009
annual scientific meetings of the ACC, AHA, and European Society of Cardiology (ESC), as …

Given its complexity, the management of atrial fibrillation (AF) has relied increasingly on
expert guideline recommendations; however, discrepancies between these professional …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing
in prevalence with age. AF is often associated with structural heart disease, although a …

Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines
Committee provides periodic reviews of new data to produce focused updates that address …

1.1. Organization of Committee and Evidence Review (UPDATED) For new or updated text,
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive
Summary: A Report of the American College of Cardiology/American Heart Association Task …